UFRJ Researchers Develop Drug to Reverse Spinal Cord Damage
A 25-year UFRJ study developed polylaminin, a placenta-derived drug that shows promise in regenerating spinal cords. The research, led by Professor Tatiana Coelho de Sampaio, head of the Extracellular Matrix Biology Laboratory at UFRJ’s Institute of Biomedical Sciences, showed that some patients regained partial or full movement after treatment. Polylaminin works by rejuvenating mature neurons […]
UFRJ Researchers Develop Drug to Reverse Spinal Cord Damage Read More »









